Baebies Announces Completion of $10 Million Series B Financing
Innovative Newborn Screening and Pediatric Testing Company Ships 2 Millionth Test - October 31, 2017
Baebies Announces Partnership with Trivitron's Labsystems Diagnostics to Bring Latest Technologies to Newborn Screening Worldwide
Customers to benefit from more high quality newborn screening platforms. - September 08, 2017
Baebies Announces CE Mark for SEEKER, an Innovative Newborn Screening Platform for Lysosomal Storage Diseases
Baebies is pleased to announce that SEEKERTM, a high throughput newborn screening laboratory solution, now has CE Mark and available in Europe and other countries that recognize CE Mark. SEEKER quantitatively measures the activity of lysosomal enzymes from newborn dried blood spot specimens. - July 31, 2017
Baebies Announces Assays for FINDER Launch Panel: G6PD, Total Serum Bilirubin, Albumin and Direct Bilirubin
Baebies, Inc., a company focused on advancing newborn screening and pediatric testing, announced the first assays on the FINDER launch panel, currently under development. The panel includes tests for total serum bilirubin, albumin, direct bilirubin, and glucose-6-phosphate dehydrogenase (G6PD) on a single cartridge, making it the first comprehensive, rapid and near-patient testing solution for hyperbilirubinemia. - July 31, 2017
Baebies Completes First Close on Series B Financing
Baebies announced today it has completed a $5 million first close on its Series B financing. - February 27, 2017
Baebies to Exhibit and Display FINDER Prototype at 2016 AACC Annual Scientific Meeting
Baebies, Inc., a company focused on advancing newborn screening and pediatric testing, today announced that the company will exhibit and display a prototype of FINDERTM at the 68th AACC Annual Scientific Meeting and Clinical Lab Expo. FINDER, currently under development, is a small, innovative and... - July 28, 2016
Baebies Appoints Former Medtronic CEO and Illumina Ventures Founding Partner to Its Board of Directors
Baebies, Inc., a company focused on advancing newborn screening and pediatric testing, today announced that William A. Hawkins and Nicholas Naclerio, PhD have joined the company’s Board of Directors effective immediately. Mr. Hawkins is the retired Chairman and CEO of Medtronic, a... - June 30, 2016